Introduction: the number of HIV exposed uninfected (HEU) infants is increasing as vertical transmission is reducing. This subpopulation requires
Introduction
The AIDS epidemic has harshly affected child mortality all over the world but intervention to prevent mother to child transmission has successfully reduced the risk of HIV transmission to < 1% in resource rich settings [1] . In sub-Saharan African regions, people living with HIV/Aids account for 70% worldwide [2] . Most of children living in this part of the world are infected via their HIV-positive mothers during pregnancy, childbirth or breastfeeding [2] . Some of them remained asymptomatic for several years despite the absence of therapy [3] , unfortunately 50% of them die before their second anniversary [4] . Despite the greatest success of ART in HIV infection history, prevention of mother to child transmission remains an important challenge especially in sub-Saharan African countries where HIV-exposed uninfected (HEU) infants are more susceptible to morbidity and mortality due to many infectious mechanisms than their unexposed peers [5] . HEU infants represent a growing population in pediatric, they can represent nearly 30% of the newborn population in some endemic nations [6] . Even if these infants are not infected, they are affected by the virus and by the treatment receive by their mother during pregnancy to prevent transmission [7] . Infection caused by the Human immunodeficiency virus type 1 (HIV-1) is characterized by a progressive and severe depletion of CD4+ T lymphocytes [8] . This phenomenon is observed in both adult and children. In adults, T cell immune activation appears to be higher in sub-Saharan Africa than in industrialized countries [9] . The understanding of the HIV-1 disease pathogenesis requires an appreciation of mechanisms involved in the loss of CD4+ T cells.
Apoptosis, one type of a programmed cell death, plays an important role in the mechanisms of HIV/AIDS infection. One apoptotic pathway is the Fas mediated mechanism during activation induced cell death (AICD) system, a key regulator of the process in normal and malignant T cells [10, 11] . Previous studies carried out on adults in Cameroon, a country characterized by a high genetic variability of HIV virus have shown the increase in plasma levels of Fas receptors (FasR) and Fas ligands (FasL) in HIV-positive compared to HIV negative individuals [12] . To date, a number of studies have shown evidence of various immunological abnormalities among HEU children [13] Blood collection: five milliliters of blood were collected from each child included in the study. Part of whole blood was used for CD4 count and the rest was centrifuged at 1,000 g for 10 minutes, plasma was aliquoted and stored at -20 o C for further analyses.
Determination of CD4 counts: CD4 cell counts were quantified using a FACScalibur flow cytometer (Becton-Dickinson, Immunocytometry System, San Jose, CA, USA).
Determination of viral load: HIV-1 viral load was determined from plasma by Abbott m2000rt Real-Time HIV-1 assay (Abbott Molecular Diagnostics, Wiesbaden, Germany), using the 200 µl protocol with a detection limit of 160 copies/ml (1.8log). Statistical analysis: data were analyzed using GraphPad prism version 6. Plasma levels of both Fas receptors and Fas ligands in HIV infected treated or naïve infants and in HIV negative, exposed uninfected and unexposed uninfected group, were compared using the Mann-Whitney U-Test. Correlation in each group of children between CD4+ cell counts and viral load was assessed using
Measurement of soluble
Spearman test, and a P-value of less than 0.05 was considered statistically significant.
Results
The overall population consists of 212 children aged from 9 months to 15 years with 112 girls (52.83%) and 100 boys (47.16). Our study population includes 88 HIV-1 infected children aged 1 to 15 years, mean ± SD (6.70 ± 3.23), 86 HIV exposed uninfected (HEU) children aged 9 months to 13 years, mean ± SD (5.53±2.01) and 38 healthy children as control group aged from 1 to 15 years, mean ± SD (7 ± 2.24). The description of the study population is summarized in Table   1 . Plasma concentrations of Fas receptors were higher than that of Fas ligands in the overall study population. Plasma concentrations of FasL were higher in HIV-1 infected children (median=136.5pg/ml IQR=91.68 pg/ml) compared to HEU and unexposed children (median=120.6 pg/ml IQR=84.40 pg/ml) with a p value of 0.009 A negative correlation was observed between the viral load and Fas receptors concentration in the same group. These two correlations are summarized in Table 2 .
Discussion
The current study aimed at measuring and evaluating the impact of uninfected children. This has been shown in some previous studies done both on children and adults [13, 14] . These two immune activation markers have been shown to correlate with HIV-1 disease progression in adults and children [15] . Massive CD4+ T cell depletion in acquired immunodeficiency syndrome (AIDS) patients may involve the death Fas receptor, but this role can also be played by other death receptors, such as the TNF and TRAIL receptors, using the same ligand ; explaining while the concentration of ligands was lower than that of receptors [16] . The activity of Fas L and Fas R can explain partly the depletion of CD4 but not fully. This result is contradictory to the findings of Sieg et al, 1997, where they showed deficiency of FasL activity on the PBMC surface of HIV infected patients [17] .
There was no statistically significant difference in the concentration of FasL between the group of HIV infected children and that of HIV exposed and uninfected children (HEU). It has been shown that HIV upregulates the expression of FasL [18] . In utero, HEU children are exposed to the virus for average 9 month, so as their infected peers.
This implies that the immune system of the HEU children is as well activated like that of HIV infected children. In addition, HEU as well as infected infants during their early life, have been exposed to ARV treatment which impacts them negatively by altering their immune system, resulting in activation [19] . They are as well exposed to cotrimoxazole as recommended by WHO, given the increased burden of morbidity and mortality in this specific group of children, particularly from pneumonia [20, 21] . The expression level of FasR in the exposed non-infected children was the lowest compared to control or HIV infected children. It has been shown that peripheral blood lymphocytes expressing FasR were more elevated in HIVinfected individuals than HIV-negative controls [22] . Low expression of FasR in HEU may be due to the elimination of the exposing agent or a bias due to low sample size or to the decrease of this FasR after exposition, transient, observed in early infancy, but no longer present later in life [23] . Further studies will be needed to elucidate on this 
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